| Literature DB >> 29352617 |
Orly Goldstein1, Mali Gana-Weisz2, Beatrice Nefussy3, Batel Vainer3, Omri Nayshool2, Anat Bar-Shira2, Bryan J Traynor4, Vivian E Drory5, Avi Orr-Urtreger6.
Abstract
We characterized the C9orf72 hexanucleotide repeat expansion (RE) mutation in amyotrophic lateral sclerosis (ALS) patients of 2 distinct origins, Ashkenazi and North Africa Jews (AJ, NAJ), its frequency, and genotype-phenotype correlations. In AJ, 80% of familial ALS (fALS) and 11% of sporadic ALS carried the RE, a total of 12.9% of all AJ-ALS compared to 0.3% in AJ controls (odds ratio [OR] = 44.3, p < 0.0001). In NAJ, 10% of fALS and 9% of sporadic ALS carried the RE, a total of 9.1% of all NAJ-ALS compared to 1% in controls (OR = 9.9, p = 0.0006). We identified a risk haplotype shared among all ALS patients, although an association with age at disease onset, fALS, and dementia were observed only in AJ. Variations were identified downstream the repeats. The risk haplotype and these polymorphisms were at high frequencies in alleles with 8 repeats or more, suggesting sequence instability. The different genotype-phenotype correlations and OR, together with the large range in age at onset, suggest that other modifiers and risk factors may affect penetrance and phenotype in ALS.Entities:
Keywords: Amyotrophic lateral sclerosis (ALS); C9orf72; Cohort studies
Mesh:
Substances:
Year: 2017 PMID: 29352617 PMCID: PMC5931221 DOI: 10.1016/j.neurobiolaging.2017.12.015
Source DB: PubMed Journal: Neurobiol Aging ISSN: 0197-4580 Impact factor: 4.673